Clinical Trial Results:
Comparison of Quetiapine Extended-Release (Seroquel XR ) and
Risperidone in the treatment of depressive symptoms, in schizophrenic or schizoaffective patients: A randomized, open label, flexible-dose, parallel group, non inferiority, 12-week study
Summary
|
|
EudraCT number |
2007-004246-32 |
Trial protocol |
IT |
Global completion date |
26 Feb 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
19 Feb 2017
|
First version publication date |
19 Feb 2017
|
Other versions |
|
Summary report(s) |
NS/D1443L00031-CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.